Table 2.
Comparison of outcomes in COVID-19 patients with and without encephalopathy. Baseline demographics and clinical outcome of Corona virus disease 2019 (COVID-19) hospitalized patients with and without encephalopathy. [NA: Not applicable].
| Unmatched analysis | |||
|---|---|---|---|
| Encephalopathy | Without encephalopathy | p-value | |
| Number of patients | 1092 | 11,509 | NA |
| Age (years) | 67.2 ± 14.9 | 61 ± 18.1 | <0.0001 |
| Female | 488 (44.7%) | 5,502 (47.8%) | 0.048 |
| Clinical outcome | |||
| Critical care services | 388 (35.5%) | 1,154 (10.0%) | <0.0001 |
| Intubation | 213 (19.5%) | 518 (4.5%) | <0.0001 |
| Death | 265 (24.3%) | 1,607 (13.9%) | <0.0001 |
| Propensity matched analysis | |||
| Encephalopathy | Without encephalopathy | p-value | |
| Number of patients | 1090 | 1090 | NA |
| Age (years) | 67.2 ± 14.9 | 67.7 ± 15.2 | 0.44 |
| Female | 488 (44.8%) | 476 (43.7%) | 0.60 |
| Clinical outcome | |||
| Critical care services | 388 (35.6%) | 184 (16.9%) | <0.0001 |
| Intubation | 213 (19.5%) | 65 (6.0%) | <0.0001 |
| Death | 265 (24.3%) | 195 (17.9%) | 0.0002 |